Company Overview of ChrysCapital
ChrysCapital is a private equity and venture capital firm specializing in management buy-outs or buy-ins, co-investments, public equity, PIPEs, growth capital in private and listed companies, and special situations including carve outs, joint ventures. The firm focuses on the business services; information technology; consumer goods and services; financial services; real estate; healthcare with a focus on pharmaceuticals, medical diagnostics and devices; infrastructure, power, and manufacturing sectors. It makes investments in companies based in or focusing on India and United States. The firm invests between $10 million and $300 million in companies with revenues ranging between $50 million...
St. James Court
Founded in 1999
Key Executives for ChrysCapital
Managing Director and Chief Financial Officer
Managing Director and Managing Partner
Compensation as of Fiscal Year 2014.
ChrysCapital Key Developments
Carlyle Reportedly Set To Acquire Destimoney From NSR
Dec 3 14
The Carlyle Group LP (NasdaqGS:CG) has come up as a frontrunner in race to acquire Destimoney Enterprises Private Limited from New Silk Route (NSR). According to the sources, the potential transaction is valued at INR 12 billion. The news report mentioned that formal announcement is due in the coming weeks. An official added, “Carlyle will most certainly buyout NSR from the housing finance JV. Last moment discussions are still on for the residual businesses like broking, distribution and I banking, which are much smaller in scale and size.” The news report mentioned that NSR and Carlyle's spokespersons declined to comment on the matter. Since 2013, NSR has been trying to monetize Destimoney investment and has had discussions with firms like General Atlantic LLC, Actis Capital, LLP, ChrysCapital and GIC Pte. Ltd. However, talks with most fell through.
ChrysCapital Presents at AVCJ Private Equity & Venture Forum - India 2014, Dec-03-2014 10:30 AM
Dec 1 14
ChrysCapital Presents at AVCJ Private Equity & Venture Forum - India 2014, Dec-03-2014 10:30 AM. Venue: Taj Lands End, Band Stand, Bandra (West), Mumbai 400 050, Maharashtra, India. Speakers: Sanjay Kukreja, Managing Director.
Warburg Pincus May Buy ChrysCap's Stake In Mankind Pharma
Nov 19 14
Warburg Pincus LLC is planning to acquire the 11% stake held by ChrysCapital in Mankind Pharma Limited for about $250 million, apart from making a primary infusion. If the deal goes through, ChrysCap would make a 9x returns on its seven year old investment.
Similar Private Companies By Industry
Recent Private Companies Transactions